{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"agammaglobulinemia-10-autosomal-dominant","columns":[{"gene":"","key":"population-7e81b4b7554a1f93e6fc","label":"Agammaglobulinemia 10, autosomal dominant","mondoId":"MONDO:0030529","onsetQualifier":null,"originColumnKey":"MONDO:0030529/OMIM:619707","originalViews":[{"key":"MONDO:0030529/OMIM:619707","label":"Agammaglobulinemia 10, autosomal dominant","scopeLabel":"OMIM:619707","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["367b455b62bcf18af42f78128d8a149b7d544fbb88dc240aaadcc04c2595ad01","4ec5d579e128a93f3881d1640ca267102720bd66e084d46ab673a7f34edc1a3c","7808fcc673faed4732db89dba318153b111102a3290ffd6f7a9a6032cf4ec08a","83f690b5dc1cf1703c8ba5125c3cb05a9725a50735dbf0cca20a7c1b3253aa93","8cd17dba6710200ec79a6267abef11e541ca3cfcd00d2b5ac6ec28bfed180a2c","c7280d0d54ccded8293f16ac7be841705f7c055e79e7282f4972adb7a51054a0","ca409ecc45b33bf5f17fb2a3bdbd2aedbacb8572504214a534053dfb749c05f6","d385277191ec689e51c84f1486cc9c9048407f760a2fb5d89c9ba82171b5a538","eb6d71a5f35e284d31056c22f8c243fb4cc6fdb8978a81b5014026bd7820a819","f2bb3f4db5003aba9946ff19e9f816bdda669b8033dd2abb001489af65a3a287"],"recordQualifiers":{},"scopeLabel":"OMIM:619707","sourceIds":["OMIM:619707"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7e81b4b7554a1f93e6fc"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030252","HP:0004432","HP:0002720","HP:0004315","HP:0002850","HP:0001287","HP:0002205"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"published":10}},"features":[{"hpoId":"HP:0030252","label":"Absent circulating B cells","primary":true},{"hpoId":"HP:0004432","label":"Agammaglobulinemia","primary":true},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":true},{"hpoId":"HP:0001287","label":"Meningitis","primary":true},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":true},{"hpoId":"HP:0011108","label":"Recurrent sinusitis","primary":false},{"hpoId":"HP:0410255","label":"Transiently decreased total neutrophil count","primary":false},{"hpoId":"HP:0100651","label":"Type I diabetes mellitus","primary":false}],"ledeHtml":"An agammaglobulinemia characterized by early-childhood onset of recurrent viral and bacterial infections affecting various organ systems, particularly the sinopulmonary system. Laboratory studies show low or absent circulating B cells and hypo- or agammaglobulinemia. Affected individuals may have adverse reactions to certain vaccinations, such as the polio vaccine. Treatment with replacement Ig is effective; hematopoietic stem cell transplantation has also been reported.","mondoId":"MONDO:0030529","node":{"canonicalSlug":"agammaglobulinemia-10-autosomal-dominant","comparisons":[{"documentSha256":"f489c7c028ff9e1cfba7367d3daed451236f51868641419526f454e9a6011f5b","key":"legacy-agammaglobulinemia-10-autosomal-dominant","kind":"legacy","label":"agammaglobulinemia 10, autosomal dominant","memberIds":["MONDO:0030529"],"mondoId":"MONDO:0030529","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/agammaglobulinemia-10-autosomal-dominant.f489c7c028ff9e1cfba7367d3daed451236f51868641419526f454e9a6011f5b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"agammaglobulinemia 10, autosomal dominant","paragraphs":["An agammaglobulinemia characterized by early-childhood onset of recurrent viral and bacterial infections affecting various organ systems, particularly the sinopulmonary system. Laboratory studies show low or absent circulating B cells and hypo- or agammaglobulinemia. Affected individuals may have adverse reactions to certain vaccinations, such as the polio vaccine. Treatment with replacement Ig is effective; hematopoietic stem cell transplantation has also been reported."],"scope":"exact","source":"MONDO","upstream":"https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:619707","url":"https://monarchinitiative.org/MONDO:0030529"},"ownColumnKeys":["population-7e81b4b7554a1f93e6fc"],"publication":"published","relationships":[{"kind":"parent","label":"agammaglobulinemia","mondoId":"MONDO:0015977","slug":"agammaglobulinemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/25595"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"367b455b62bcf18af42f78128d8a149b7d544fbb88dc240aaadcc04c2595ad01","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0410255","is_excluded":false,"label":"Transiently decreased total neutrophil count","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4ec5d579e128a93f3881d1640ca267102720bd66e084d46ab673a7f34edc1a3c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7808fcc673faed4732db89dba318153b111102a3290ffd6f7a9a6032cf4ec08a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"83f690b5dc1cf1703c8ba5125c3cb05a9725a50735dbf0cca20a7c1b3253aa93","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0011108","is_excluded":false,"label":"Recurrent sinusitis","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8cd17dba6710200ec79a6267abef11e541ca3cfcd00d2b5ac6ec28bfed180a2c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0100651","is_excluded":false,"label":"Type I diabetes mellitus","onset_id":"HP:0011463","reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c7280d0d54ccded8293f16ac7be841705f7c055e79e7282f4972adb7a51054a0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0030252","is_excluded":false,"label":"Absent circulating B cells","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ca409ecc45b33bf5f17fb2a3bdbd2aedbacb8572504214a534053dfb749c05f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0001287","is_excluded":false,"label":"Meningitis","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d385277191ec689e51c84f1486cc9c9048407f760a2fb5d89c9ba82171b5a538","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eb6d71a5f35e284d31056c22f8c243fb4cc6fdb8978a81b5014026bd7820a819","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0004432","is_excluded":false,"label":"Agammaglobulinemia","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f2bb3f4db5003aba9946ff19e9f816bdda669b8033dd2abb001489af65a3a287","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619707","disease_name":"Agammaglobulinemia 10, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"PMID:33951726","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030529\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:619707</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An agammaglobulinemia characterized by early-childhood onset of recurrent viral and bacterial infections affecting various organ systems, particularly the sinopulmonary system. Laboratory studies show low or absent circulating B cells and hypo- or agammaglobulinemia. Affected individuals may have adverse reactions to certain vaccinations, such as the polio vaccine. Treatment with replacement Ig is effective; hematopoietic stem cell transplantation has also been reported.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030529\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"agammaglobulinemia-10-autosomal-dominant","sourceDocuments":[{"name":"MONDO: agammaglobulinemia 10, autosomal dominant","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0030529"}],"sourceNote":"","synonyms":["AGM10"],"takeawayHtml":"","title":"agammaglobulinemia 10, autosomal dominant"},"schemaVersion":1}
